Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Acarbose treatment shows major benefits for type 2s….
Read More »SGLT2 Inhibitors and Risk of UTI Development in Patients with Diabetes
Does the newest class of diabetes medications increase UTI development?…
Read More »Dieting During Pregnancy
Inadequate diet causing diabetes in newborns….
Read More »Why Do SGLT2 Inhibitors Inhibit Only 30-50% of the Glucose Load Filtered in the Kidneys?
SGLT1 may play a more significant role than previously thought….
Read More »Effectiveness of Shared Medical Appointments in Diabetes Care
Shared medical appointments show promise in treating veterans with diabetes….
Read More »New Dual-Action Drug Shows Promise in Diabetes and Obesity
An experimental two-hormone drug shows promise in diabetes and obesity….
Read More »Type 2 Youths Get Earlier Onset of Complications than Type 1’s
The onset of diabetes complications appear much earlier in youth with….
Read More »HbA1c Variability a Predictor for Macrovascular Complications in Type 2’s
HbA1c variability may not impact CVD….
Read More »Mechanism of Increased Appetite Stimulation in Obese Individuals
Obese individuals often have increased appetite despite normal and lower plasma levels of the main appetite stimulant hormone ghrelin….
Read More »What Should the Initial Medication Be for Type 2 Diabetes?
Acarbose is similar to metformin in efficacy in new study….
Read More »